The U.S. Environmental Protection Agency (EPA) has adopted a novel approach to “defending” the tighter limits on ozone and PM2.5 adopted...

The Homeowners Market Data Call (C) Task Force (the “Task Force”) oversees the Homeowners Market Data Call and is responsible for...

On December 10, 2025, the Cybersecurity (H) Working Group met to discuss, and receive comments regarding, its proposed Cybersecurity...

In an efficient meeting on December 10, 2025, the Producer Licensing (D) Task Force received a report from the National Insurance...

The Mental Health Parity and Addiction Equity Act (B) Working Group (the “Working Group”) monitors developments related to the Mental...

The mission of the Climate and Resiliency (EX) Task Force is to serve as the coordinating NAIC body for discussion and engagement on...

On December 9, 2025, the Reinsurance (E) Task Force, which reports to the Financial Condition (E) Committee, met to discuss, among other...

On December 9, 2025, the Third-Party Data and Models (H) Working Group, which reports to the Innovation Cybersecurity and Technology (H)...

FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,...

Texas S.B. 840 and S.B. 2477, effective September 1, 2025, significantly curtail how larger Texas cities regulate mixed-use and...

Artificial intelligence (AI) is transforming health care and biotechnology, propelling advancements in drug discovery, genomics, medical...

What you will learn: The summit’s discussions highlighted the importance of vertical integration, material innovations such as mass...

The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors...

On October 8, California Governor Newsom signed AB 566, which adds a section to the California Privacy Protection Agency (CCPA) to...

For a decade, innovators at the intersection of artificial intelligence (AI) and precision medicine have faced a stubborn paradox: the...

A Blueprint for FDA: Recommendations to Improve Innovation and Access [1] (FDA Blueprint) is a timely white paper authored by University...